Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.35 is 81% above its 5-year average of 4.61, near the high end of its 5-year range (0.00–11.81).
As of the fiscal period ended Tuesday, June 30, 2026. 46.43% above its 12-month average of 5.70.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.35.
CURRENT RATIO
8.35
CURRENT RATIO AVG TTM
5.70
CURRENT RATIO AVG 3Y
4.94
CURRENT RATIO AVG 5Y
4.61
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+46.43%
CURRENT VS 3Y AVG
+68.80%
CURRENT VS 5Y AVG
+80.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+121.99%
vs the sector median at left
Market Cap
$500.52M
Current Ratio
4.12
TTM Avg
4.20
3Y Avg
3.45
5Y Avg
3.62
Market Cap
$502.81M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$503.93M
Current Ratio
10.72
TTM Avg
8.23
3Y Avg
9.67
5Y Avg
9.58
Market Cap
$504.04M
Current Ratio
9.66
TTM Avg
5.09
3Y Avg
5.58
5Y Avg
6.85
Market Cap
$483.54M
Current Ratio
2.91
TTM Avg
1.77
3Y Avg
1.71
5Y Avg
1.57
Market Cap
$516.76M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $498.52M | 8.35 | 5.70 | 4.94 | 4.61 |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 4.12 | 4.20 | 3.45 | 3.62 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | 5.42 | 12.18 | 12.18 | 12.18 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | 10.72 | 8.23 | 9.67 | 9.58 |
| Crescent Biopharma, Inc. (CBIO)vs › | $504.04M | 9.66 | 5.09 | 5.58 | 6.85 |
| 908 Devices Inc. (MASS)vs › | $505.87M | 2.67 | 4.17 | 6.82 | 10.02 |
| Evolus, Inc. (EOLS)vs › | $486.01M | 1.70 | 2.15 | 2.20 | 2.10 |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 2.91 | 1.77 | 1.71 | 1.57 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | 3.46 | 4.63 | 6.00 | 6.13 |
| Altimmune, Inc. (ALT)vs › | $519.25M | 26.78 | 15.83 | 15.06 | 15.09 |
Current Ratio
8.35
Quick Ratio
8.35
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.35 |
| 2026-03-31 | 5.18 |
| 2025-12-31 | 5.96 |
| 2025-09-30 | 4.47 |
| 2025-06-30 | 4.55 |
| 2025-03-31 | 4.79 |
| 2024-12-31 | 2.37 |
| 2024-09-30 | 4.02 |
| 2024-06-30 | 5.27 |
| 2024-03-31 | 4.71 |
| 2023-12-31 | 5.29 |
| 2023-09-30 | 5.21 |
| 2023-06-30 | 7.22 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 1.97 |
| 2022-09-30 | 3.91 |
| 2022-06-30 | 4.27 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 11.81 |
| 2021-09-30 | 0.00 |
